Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 41
Filtrar
Más filtros

Medicinas Complementárias
Intervalo de año de publicación
1.
J Eur Acad Dermatol Venereol ; 30(1): 83-5, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25627163

RESUMEN

BACKGROUND: Psoriasis has been linked to increased malignancy risk, particularly lympho-haematopoietic and non-melanoma skin cancers; however, its association with cutaneous melanoma remains unclear. OBJECTIVE: The aim of this study was to determine if there is an association between melanoma and psoriasis in a large, urban academic population through an electronic medical record database. METHODS: We searched our institution's electronic medical record database (EDW-Electronic Data Warehouse) from 1/2001 to 11/2013. Subjects were identified by ICD-9 codes. Melanoma diagnosis was included only if documented at least 1 month after the psoriasis diagnosis was documented. Odds ratio (OR) was obtained for association between cutaneous melanoma and psoriasis. The OR was then adjusted for phototherapy and age. To minimize detection bias, we also obtained the OR for association between cutaneous melanoma and atopic dermatitis. RESULTS: We identified 10 947 patients with psoriasis, 64 of whom had a subsequent diagnosis of cutaneous melanoma. We detected a significant association between melanoma and psoriasis (OR = 1.77; 95%CI 1.38-2.26; P < 0.0001; total n = 1 525 252). After adjusting for phototherapy and age, a statistically significant association between melanoma and psoriasis remained detectable (OR = 1.9; 95%CI 1.55-2.55; P < 0.0001 and OR = 1.64; 95%CI 1.17-2.26; P = 0.003 respectively). The OR for melanoma with atopic dermatitis in the same patient database showed a statistically significant inverse association between the two diseases (OR = 0.35; 95%CI 0.16-0.73; P = 0.005). CONCLUSION: Our findings show a statistically significant association between psoriasis and melanoma. After adjusting the OR for phototherapy and age, a statistically significant association remained. Further investigations exploring these associations are warranted in order to establish the relative risk for melanoma in psoriasis patients.


Asunto(s)
Melanoma/complicaciones , Psoriasis/complicaciones , Neoplasias Cutáneas/complicaciones , Anciano , Estudios Transversales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Factores de Riesgo , Población Urbana , Melanoma Cutáneo Maligno
2.
J Anim Sci ; 91(3): 1255-69, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23296836

RESUMEN

Mortality in swine herds is often associated with lameness, and trace minerals are implicated in maintaining integrity of skeletal tissues. The objectives of this study were to determine if prolific sows displayed evidence of trace mineral depletion with age and to determine the prevalence of osteochondrosis (OC) lesions. Reduced mineral concentrations with age would support recommendations for an increase in the amount of dietary minerals. Tissue samples were collected from 66 sows selected to represent a cross-sectional profile of a prolific herd fed diets with inorganic sources of trace minerals fortified at concentrations typically found in commercial diets. Females ranged from nulliparous (parity 0) to parity 7 with a lifetime average of 12.9 ± 0.5 pigs born alive per litter. Minerals were assessed in humerus, scapula, ovary, liver, and muscle (psoas major) tissues. Percent bone ash increased (P < 0.05) with parity from 64 to 66% but differed among bone sections. The Ca (39.0%) and P (18.9%) concentrations in bone ash were essentially constant in all sections and parities. Bone Cu, Fe, Mn, and Zn concentrations varied among sections, but differences due to parity (P < 0.05) were only detected in Fe. Bone Fe decreased from approximately 49 µg/g ash in parity 0 and 1 sows to approximately 29 µg/g ash in parity 7, likely reflecting loss of hemopoietic tissue with age. No evidence was detected in liver for depletion of trace minerals across parity; however, liver Cu and Zn concentrations tended to increase with age. Liver Mn concentrations varied with parity, but no consistent trend with parity was evident. Ovary Cu and Mn concentrations varied dramatically as a function of the reproductive status, but no evidence was detected for depletion with parity. Articular surfaces of the distal scapula and proximal and distal humerus were evaluated grossly for prevalence of OC; bones were then sectioned to evaluate lesions in subchondral bone and physis. Incidence of OC lesions on the articular-epiphyseal cartilage complex varied among bone sites, but differences across parities were not detected. In a subset of sows with subchondral bone lesions, the lesions appeared severe enough to contribute to clinical lameness, particularly in the distal humerus site. However, none of the sows exhibited lameness at slaughter. As no reductions in mineral concentrations with age were detected, recommendations to increase dietary mineral supplementation with age were not supported.


Asunto(s)
Minerales/metabolismo , Osteocondrosis/veterinaria , Enfermedades de los Porcinos/patología , Oligoelementos/deficiencia , Envejecimiento , Animales , Huesos/química , Dieta/veterinaria , Femenino , Fertilidad , Hígado/metabolismo , Minerales/análisis , Osteocondrosis/inducido químicamente , Osteocondrosis/epidemiología , Osteocondrosis/patología , Ovario/metabolismo , Paridad , Embarazo , Prevalencia , Músculos Psoas/metabolismo , Porcinos/fisiología , Enfermedades de los Porcinos/inducido químicamente , Enfermedades de los Porcinos/epidemiología
3.
Eur J Histochem ; 56(2): e14, 2012 May 09.
Artículo en Inglés | MEDLINE | ID: mdl-22688295

RESUMEN

Inflammation following ischaemic stroke attracts high priority in current research, particularly using human-like models and long-term observation periods considering translational aspects. The present study aimed on the spatio-temporal course of macrophage-like cell accumulation after experimental thromboembolic stroke and addressed microglial and astroglial reactions in the ischaemic border zone. Further, effects of tissue plasminogen activator (tPA) as currently best treatment for stroke and the potentially neuroprotective co-administration of hyperbaric oxygen (HBO) were investigated. Rats underwent middle cerebral artery occlusion and were assigned to control, tPA or tPA+HBO. Twenty-four hours, 7, 14 and 28 days were determined as observation time points. The accumulation of macrophage-like cells was semiquantitatively assessed by CD68 staining in the ischaemic area and ischaemic border zone, and linked to the clinical course. CD11b, ionized calcium binding adaptor molecule 1 (Iba), glial fibrillary acidic protein (GFAP) and Neuronal Nuclei (NeuN) were applied to reveal delayed glial and neuronal alterations. In all groups, the accumulation of macrophage-like cells increased distinctly from 24 hours to 7 days post ischaemia. tPA+HBO tended to decrease macrophage-like cell accumulation at day 14 and 28. Overall, a trend towards an association of increased accumulation and pronounced reduction of the neurological deficit was found. Concerning delayed inflammatory reactions, an activation of microglia and astrocytes with co-occurring neuronal loss was observed on day 28. Thereby, astrogliosis was found circularly in contrast to microglial activation directly in the ischaemic area. This study supports previous data on long-lasting inflammatory processes following experimental stroke, and additionally provides region-specific details on glial reactions. The tendency towards a decreasing macrophage-like cell accumulation after tPA+HBO needs to be discussed critically since neuroprotective properties were recently ascribed to long-term inflammatory processes.


Asunto(s)
Fibrinolíticos/farmacología , Oxigenoterapia Hiperbárica , Embolia Intracraneal , Macrófagos , Accidente Cerebrovascular , Activador de Tejido Plasminógeno/farmacología , Animales , Antígenos de Diferenciación/metabolismo , Humanos , Embolia Intracraneal/metabolismo , Embolia Intracraneal/patología , Embolia Intracraneal/terapia , Macrófagos/metabolismo , Macrófagos/patología , Masculino , Ratas , Ratas Sprague-Dawley , Accidente Cerebrovascular/metabolismo , Accidente Cerebrovascular/patología , Accidente Cerebrovascular/terapia , Factores de Tiempo
4.
Acta Neurol Scand ; 123(2): 85-97, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20456243

RESUMEN

High socioeconomic burden is attributed to acute ischemic stroke, but treatment strategies are still limited. Normobaric (NBO) and hyperbaric oxygen therapy (HBO) were frequently investigated in preclinical studies following acute focal cerebral ischemia with predominantly beneficial effects in different outcome measurements. Best results were achieved in transient cerebral ischemia, starting HBO early after artery occlusion, and by using relatively high pressures. On molecular level, oxygen application leads to blood-brain barrier stabilization, reduction of excitotoxic metabolites, and inhibition of inflammatory processes. Therefore, NBO and HBO appear excessively hopeful in salvaging impaired brain cells during ischemic stroke. However, harmful effects have been noted contributing to damaging properties, for example, vasoconstriction and free oxygen radicals. In the clinical setting, NBO provided positive results in a single clinical trial, but HBO failed to show efficacy in three randomized trials. To date, the translation of numerous evidentiary experimental results into clinical implementation remains open. Recently, oxygen became interesting as an additional therapy to neuroprotective or recanalization drugs to combine positive effects. Further preclinical research is needed exploring interactions between NBO, HBO, and key factors with multiphasic roles in acute damaging and delayed inflammatory processes after cerebral ischemia, for example, matrix-metalloproteinases and hypoxia-inducible factor-1α.


Asunto(s)
Ensayos Clínicos como Asunto , Oxigenoterapia Hiperbárica , Ataque Isquémico Transitorio/terapia , Oxígeno/administración & dosificación , Animales , Bases de Datos Factuales/estadística & datos numéricos , Modelos Animales de Enfermedad , Humanos
5.
Gesundheitswesen ; 72(3): 161-2, 2010 Mar.
Artículo en Alemán | MEDLINE | ID: mdl-20306376

RESUMEN

Considering obesity as an example, the present study has developed an ethical, legal and psychological understanding of personal responsibility, which aims at enabling and activating health promoting behaviour. Enhancing individual capabilities and modifying social and political factors that have an effect on individual behaviour are highlighted as a promising, appropriate and ethically sound strategy of prevention.


Asunto(s)
Conducta Cooperativa , Conductas Relacionadas con la Salud , Comunicación Interdisciplinaria , Estilo de Vida , Obesidad/prevención & control , Responsabilidad Social , Estudios Transversales , Ética Médica , Conducta Alimentaria/ética , Alemania , Promoción de la Salud/ética , Humanos , Programas Nacionales de Salud , Obesidad/epidemiología , Poder Psicológico , Autocuidado/ética , Autocuidado/métodos
6.
Int J Hyperthermia ; 22(6): 451-61, 2006 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16971366

RESUMEN

PURPOSE: In children with locally advanced or recurrent malignant tumours, prognosis can be improved by regional deep hyperthermia (RHT) in combination with platin-based chemotherapy. However, because of the increasing number of patients that achieve long-time remission with this therapy, it is necessary to evaluate long-term sequelae of thermochemotherapy. During the years 1993-2004 one has observed avascular osteonecrosis (AON) of the femoral head after RHT in seven children with pelvic germ cell tumours or rhabdomyosarcomas. METHODS: Although AON may develop in patients with malignancies treated with chemo- or radiotherapy alone, RHT might nevertheless contribute to the occurrence of AON. In order to determine potential risk factors for AON after RHT, this study analysed the relationship of AON to the patient's age, medical history and treatment parameters such as thermal dose equivalent and power output. RESULTS AND CONCLUSIONS: In the present study AON was associated with young age as well as intensity of hyperthermia indicated by high power levels that exceed 20 W per kg body weight and/or application of eight or more heat sessions as well as additional radiotherapy. Based on this observation, it was assumed that an optimized three dimensional thermal field modelling may be helpful to avoid hazardous temperatures in the femoral heads during RHT treatment and to reduce AON of the femoral heads.


Asunto(s)
Hipertermia Inducida/efectos adversos , Osteonecrosis/etiología , Neoplasias Pélvicas/terapia , Adolescente , Adulto , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Niño , Preescolar , Terapia Combinada , Femenino , Humanos , Lactante , Masculino , Persona de Mediana Edad , Neoplasias de Células Germinales y Embrionarias/tratamiento farmacológico , Neoplasias de Células Germinales y Embrionarias/terapia , Neoplasias Pélvicas/tratamiento farmacológico , Estudios Retrospectivos , Rabdomiosarcoma/tratamiento farmacológico , Rabdomiosarcoma/terapia , Factores de Riesgo
7.
Neurochem Int ; 45(8): 1125-32, 2004 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15380622

RESUMEN

Hyperbaric oxygen treatment has been suggested as able to reduce hypoxia induced neuronal damage. The aim of the study was to compare the impact of different reoxygenation strategies on early metabolical (purine nucleotide content determined by HPLC) and morphological changes (index of cell injury after celestine blue/acid fuchsin staining) of hypoxically damaged rat neocortical brain slices. For this purpose slices (300 microm and 900 microm) were subjected to either 5 or 30 min of hypoxia by gassing the incubation medium with nitrogen. During the following reoxygenation period treatment groups were administered either 100% oxygen (O) or room air (A) at normobaric (1 atm absolute, NB-O; NB-A) or hyperbaric (2.5 atm absolute, HB-O; HB-A) conditions. After 5 min of hypoxia, both HB-O and NB-O led to a complete nucleotide status restoration (ATP/ADP; GTP/GDP) in 300 microm slices. However, reoxygenation after 30 min of hypoxia was less effective, irrespective of the oxygen pressure. Furthermore, administering hyperbaric room air resulted in no significant posthypoxic nucleotide recovery. In 900 microm slices, both control incubation as well as 30 min of hypoxia resulted in significantly lower trinucleotide and higher dinucleotide levels compared to 300 microm slices. While there was no significant difference between HB-O and NB-O on the nucleotide status, morphological evaluation revealed a better recovery of the index of cell injury (profoundly injured/intact cell-ratio) in the HB-O group. Conclusively, the posthypoxic recovery of metabolical characteristics was dependent on the duration of hypoxia and slice thickness, but not on the reoxygenation pressure. A clear restorative effect on purine nucleotides was found only in early-administered HB-O as well as NB-O in contrast to room air treated slices. However, these pressure independent metabolic changes were morphologically accompanied by a significantly improved index of cell injury, indicating a possible neuroprotective role of HB-O in early posthypoxic reoxygenation.


Asunto(s)
Química Encefálica/fisiología , Encéfalo/patología , Oxigenoterapia Hiperbárica , Hipoxia-Isquemia Encefálica/metabolismo , Hipoxia-Isquemia Encefálica/patología , Terapia por Inhalación de Oxígeno , Nucleótidos de Purina/metabolismo , Adenosina Difosfato/metabolismo , Adenosina Trifosfato/metabolismo , Animales , Recuento de Células , Supervivencia Celular/fisiología , Cromatografía Líquida de Alta Presión , Colorantes , Metabolismo Energético/fisiología , Guanosina Difosfato/metabolismo , Guanosina Trifosfato/metabolismo , Técnicas In Vitro , Masculino , Neocórtex/metabolismo , Neocórtex/patología , Ratas , Ratas Wistar
8.
J Neurol Sci ; 219(1-2): 77-82, 2004 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-15050441

RESUMEN

INTRODUCTION: Severe brain injury is one of the most frequent causes of severe disability in the young. In acute management of brain trauma, new approaches based on experimental animal investigations should be sought. METHODS: Twenty male, juvenile Chinchilla-Bastard rabbits received standardized cold-injury-induced-brain-trauma (CIBT). A metal probe (temperature -196 degrees C) was applied epidurally over 10 s. The hyperbaric oxygenation (HBO) group (n=10) underwent 90-min HBO sessions with 100% oxygen at 2.5 atmospheres absolute (1 h, 24+/-2 h, 48+/-2 h after CIBT). Cerebral tissue pO2-measurements were performed 60 min after CIBT, during the three HBO sessions and on day 4. The control group (n=10) underwent no treatment. Animals were sacrificed on day 4, and brains were analyzed histologically. RESULTS: In the HBO group, pO2 measurements showed a significant increase in pO2 between day 1 and day 4, whereas no significant changes were observed in the control group. During the first HBO session, mean pO2 was 169 mm Hg, during the second 305 mm Hg and during the third 420 mm Hg. The mean area of necrosis was 16.2 mm2 in the HBO group, in the control group 19.9 mm2. The areas of brain edema were significantly smaller in the HBO group. Mortality in the HBO group was 0%, in the control group 20%. CONCLUSION: HBO appears to be beneficial as an adjunct treatment of severe head trauma. To find optimal treatment protocols, further clinical studies must be developed.


Asunto(s)
Edema Encefálico/metabolismo , Lesiones Encefálicas/metabolismo , Oxigenoterapia Hiperbárica , Monitoreo Fisiológico/métodos , Oxígeno/metabolismo , Animales , Encéfalo/metabolismo , Encéfalo/patología , Edema Encefálico/patología , Edema Encefálico/terapia , Lesiones Encefálicas/patología , Lesiones Encefálicas/terapia , Modelos Animales de Enfermedad , Masculino , Necrosis , Presión Parcial , Conejos , Organismos Libres de Patógenos Específicos
9.
Klin Padiatr ; 215(6): 303-9, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-14677093

RESUMEN

BACKGROUND: Elevated temperatures of 40 - 44 degrees C increase the actions of various anticancer drugs including N-lost derivatives, cytotoxic antibiotics and platinum analoga. In clinical usage thermochemotherapy (TCH) should facilitate surgical resection and ameliorate local tumor control. PATIENTS AND METHODS: From 07/1993 to 12/2002 a total of 39 patients have been enrolled onto a phase-II study (female = 24, male = 15, age 1 - 37.5 years, median 5.2). Among these, 24 patients had extracranial non-testicular germ cell tumors and 15 patients soft tissue or chondrosarcomas. INDICATION: locoregional relapse (n = 29) or unresectable tumor after neoadjuvant chemotherapy (n = 10). Among these two groups, there were ten patients with poor response or progressive disease under primary or relapse chemotherapy. Ten out of the 29 relapse patients had more than one relapse. Tumor site: pelvis (30), abdomen (4), head and neck (2), proximal leg (2) and lumbar spine (1). Thermochemotherapy (TCH): 1800 - 2000 mg ifosfamide/m (2) and 100 mg etoposide/m (2) on days 1 - 4 and 40 mg cisplatin/m (2) on days 1 + 4 combined with regional deep hyperthermia (42 - 44 degrees C, 1 h) on days 1 + 4. RESULTS: In 39 protocol patients a total of 166 TCH courses (332 heat sessions) were applied. 20 patients achieved complete response, and 10 patients achieved partial response. TCH was followed by surgical tumor resection in 28/39 patients and/or radiotherapy in 13/39 patients. At a median follow-up of 27 months, outcome in this high-risk patient population was 22 NED, 3 AWD, 12 DOD, 2 DOC. Five year event free (EFS) and overall survival (OS) for the whole study cohort was 0.39 +/- 0.11 (20/39 patients) and 0.52 +/- 0.11 (25/39 patients), respectively. CONCLUSION: TCH shows substantial therapeutic efficacy and facilitates complete tumor resection in 14 out of 28 operated patients. Multimodal treatment including TCH, surgical resection and/or radiotherapy leads to sustained remission in the majority of patients with locoregional tumor recurrence. The therapeutic effect is most pronounced, if TCH is administered at first relapse. Due to the clinical and histologic heterogeneity the number of patients eligible for TCH is limited. Therefore, a more valid assessment of treatment efficacy can only be made by a matched-pair comparison in cooperation with the clinical registers.


Asunto(s)
Neoplasias Abdominales/terapia , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias Óseas/terapia , Condrosarcoma/terapia , Cisplatino/uso terapéutico , Etopósido/uso terapéutico , Germinoma/terapia , Neoplasias de Cabeza y Cuello/terapia , Hipertermia Inducida , Ifosfamida/uso terapéutico , Vértebras Lumbares , Neoplasias Pélvicas/terapia , Sarcoma/terapia , Neoplasias de los Tejidos Blandos/terapia , Neoplasias de la Columna Vertebral/terapia , Neoplasias Abdominales/tratamiento farmacológico , Neoplasias Abdominales/radioterapia , Neoplasias Abdominales/cirugía , Adolescente , Adulto , Neoplasias Óseas/tratamiento farmacológico , Neoplasias Óseas/radioterapia , Neoplasias Óseas/cirugía , Quimioterapia Adyuvante , Distribución de Chi-Cuadrado , Niño , Preescolar , Condrosarcoma/tratamiento farmacológico , Condrosarcoma/radioterapia , Condrosarcoma/cirugía , Terapia Combinada , Interpretación Estadística de Datos , Femenino , Estudios de Seguimiento , Germinoma/tratamiento farmacológico , Germinoma/radioterapia , Germinoma/cirugía , Neoplasias de Cabeza y Cuello/tratamiento farmacológico , Neoplasias de Cabeza y Cuello/radioterapia , Neoplasias de Cabeza y Cuello/cirugía , Humanos , Lactante , Estado de Ejecución de Karnofsky , Masculino , Terapia Neoadyuvante , Recurrencia Local de Neoplasia , Neoplasias Pélvicas/tratamiento farmacológico , Neoplasias Pélvicas/radioterapia , Neoplasias Pélvicas/cirugía , Sarcoma/tratamiento farmacológico , Sarcoma/radioterapia , Sarcoma/cirugía , Neoplasias de los Tejidos Blandos/tratamiento farmacológico , Neoplasias de los Tejidos Blandos/radioterapia , Neoplasias de los Tejidos Blandos/cirugía , Neoplasias de la Columna Vertebral/tratamiento farmacológico , Neoplasias de la Columna Vertebral/radioterapia , Neoplasias de la Columna Vertebral/cirugía , Factores de Tiempo , Resultado del Tratamiento
10.
Arzneimittelforschung ; 51(10): 799-805, 2001 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11715632

RESUMEN

Oxidation of low density lipoprotein (LDL) has been implicated in atherogenesis since several years. Therefore many researchers are looking for potent antioxidants which are able to inhibit LDL-oxidation and thus lower the risk for atherosclerosis. In particular several flavonoids have been investigated for their antioxidant capacity and it was shown that many factors influence the ability of flavonoids to retard LDL-oxidation, among others their lipophilic character. Since essential oils and some of their components which are highly lipophilic, have been shown to possess antioxidant properties, their effects on copper-induced LDL-oxidation were analysed. Plasma was incubated with different terpenoid substances and subsequently the LDL was isolated. It could be demonstrated that the terpenoids were enriched in LDL after incubation with plasma. To follow the kinetics of copper induced LDL-oxidation formation of conjugated dienes as well as loss of tryptophan fluorescence were measured. Furthermore the antioxidants alpha-tocopherol, beta-carotene and lycopene were quantified in LDL. It could be shown that particularly lemon oil and one of its components, gamma-terpinene, are efficiently slowing down the oxidation of LDL. This effect is independent of alpha-tocopherol stability in LDL, whereas the loss of carotenoids during oxidation is strongly retarded.


Asunto(s)
Antioxidantes/química , Citrus/química , Cobre/química , Lipoproteínas LDL/química , Aceites de Plantas/química , Carotenoides/química , Cromatografía de Gases , Cinética , Licopeno , Oxidación-Reducción , Triptófano/química , Vitamina E/química , beta Caroteno/química
11.
J Bone Miner Res ; 16(1): 135-40, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11149477

RESUMEN

Vitamin C is known to stimulate procollagen, enhance collagen synthesis, and stimulate alkaline phosphatase activity, a marker for osteoblast formation. Studies of dietary vitamin C intake and the relation with bone mineral density (BMD) have been conflicting, probably because of the well-known limitations of dietary nutrient assessment questionnaires. The purpose of this study was to evaluate the independent relation of daily vitamin C supplement use with BMD in a population-based sample of postmenopausal women. Subjects were 994 women from a community-based cohort of whom 277 women were regular vitamin C supplement users. Vitamin C supplement use was validated. Daily vitamin C supplement intake ranged from 100 to 5,000 mg; the mean daily dose was 745 mg. Average duration of use was 12.4 years; 85% had taken vitamin C supplements for more than 3 years. BMD levels were measured at the ultradistal and midshaft radii, hip, and lumbar spine. After adjusting for age, body mass index (BMI), and total calcium intake, vitamin C users had BMD levels approximately 3% higher at the midshaft radius, femoral neck, and total hip (p < 0.05). In a fully adjusted model, significant differences remained at the femoral neck (p < 0.02) and marginal significance was observed at the total hip (p < 0.06). Women taking both estrogen and vitamin C had significantly higher BMD levels at all sites. Among current estrogen users, those also taking vitamin C had higher BMD levels at all sites, with marginal significance achieved at the ultradistal radius (p < 0.07), femoral neck (p < 0.07), and total hip (p < 0.09). Women who took vitamin C plus calcium and estrogen had the highest BMD at the femoral neck (p = 0.001), total hip (p = 0.05), ultradistal radius (p = 0.02), and lumbar spine. Vitamin C supplement use appears to have a beneficial effect on levels of BMD, especially among postmenopausal women using concurrent estrogen therapy and calcium supplements.


Asunto(s)
Ácido Ascórbico/farmacología , Densidad Ósea/efectos de los fármacos , Suplementos Dietéticos , Posmenopausia/efectos de los fármacos , Factores de Edad , Anciano , Anciano de 80 o más Años , Ácido Ascórbico/administración & dosificación , Índice de Masa Corporal , Huesos/efectos de los fármacos , Huesos/metabolismo , Calcio/administración & dosificación , Calcio/farmacología , California , Estudios de Cohortes , Estrógenos/farmacología , Femenino , Humanos , Persona de Mediana Edad , Encuestas y Cuestionarios
12.
Physiol Genomics ; 3(2): 113-20, 2000 Aug 09.
Artículo en Inglés | MEDLINE | ID: mdl-11015606

RESUMEN

Possible adverse interactions between an usually inconspicuous genetic trait and early environmental factors favoring the development of obesity were investigated in rats heterozygous for the leptin receptor defect "fatty" (fa). Pups were exposed to early postnatal overfeeding by reducing litter size from normally 10-12 to only 4. Rearing +/+ and +/fa pups from day 3 to 21 in small litters increased fat-free dry mass and body fat, but only in the latter did a significant interaction with genotype occur. Pronounced differences in the responsiveness of +/+ and +/fa pups to "prophylactic" leptin treatment (from day 1 to 21) were observed, with +/fa females from small litters being nearly as fat and unresponsive as previously reported for normally reared fa/fa pups. Clear heterozygous differences in total hypothalamic leptin binding, but no litter size effect, paralleling the differences in leptin responsiveness, were observed. By early postnatal overfeeding an usually inconspicuous genetic trait may thus become etiologic for the development of obesity via physiological changes other than the decreased leptin binding characterizing the genetic defect.


Asunto(s)
Proteínas Portadoras/metabolismo , Ambiente , Predisposición Genética a la Enfermedad , Leptina/metabolismo , Obesidad/genética , Receptores de Superficie Celular , Tejido Adiposo/efectos de los fármacos , Tejido Adiposo/crecimiento & desarrollo , Análisis de Varianza , Animales , Composición Corporal/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Femenino , Eliminación de Gen , Heterocigoto , Homocigoto , Hipotálamo/metabolismo , Análisis de los Mínimos Cuadrados , Leptina/sangre , Leptina/farmacología , Tamaño de la Camada , Masculino , Obesidad/sangre , Ratas , Ratas Mutantes , Ratas Zucker , Receptores de Leptina , Programas Informáticos
13.
Eur J Clin Nutr ; 54(1): 29-35, 2000 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-10694769

RESUMEN

OBJECTIVE: To assess the impact of a daily oral iron supplementation on hematological status, cell-mediated immunity and susceptibility to infections in children living in an environment where iron deficiency, malaria and other infections are frequent. DESIGN: Randomized, double-blind iron supplementation including a placebo group. SETTING: A village in Togo, West Africa. SUBJECTS: Of the 229 6-36-month-old children of both sexes recruited, 197 with hemoglobin concentration >/=80 g/l were included and 163 completed the study. INTERVENTION: Children received daily a placebo (n=79) or a dose of 2-3 mg of elemental iron per kg of body weight (n=84) for 3 months. Hematological, nutritional and immune status were assessed at the beginning and at the end of the supplementation period, and 6 months later. Morbidity was recorded throughout the study. RESULTS: Iron supplementation had a significant and positive effect on iron status of children and no impact on the incidence of infections, especially malaria. Its probable effect on immune status was masked by interference of infections and their treatment, which contributed to improve hematological and immune status in both groups. CONCLUSION: According to the negative consequences of anemia and iron deficiency on global child development, control of iron deficiency by oral iron supplementation in young children has to be conducted, associated with prophylaxis and treatment of malaria and repeated deworming. SPONSORSHIP: Program supported by IRD. European Journal of Clinical Nutrition (2000) 54, 29-35


Asunto(s)
Anemia/inmunología , Inmunidad Celular/efectos de los fármacos , Hierro/administración & dosificación , Análisis de Varianza , Anemia/complicaciones , Anemia/epidemiología , Preescolar , Método Doble Ciego , Femenino , Ferritinas/sangre , Hemoglobinas/efectos de los fármacos , Humanos , Incidencia , Lactante , Infecciones/epidemiología , Infecciones/etiología , Infecciones/inmunología , Hierro/inmunología , Hierro/uso terapéutico , Malaria/epidemiología , Malaria/etiología , Masculino , Estado Nutricional , Togo/epidemiología
14.
Int Tinnitus J ; 6(1): 56-62, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-14689620

RESUMEN

Tinnitus is one of the most important symptoms in neurootology after vertigo, nausea, and hearing loss. In most cases, the origin of the tinnitus remains inexplicable. Well-known, however, is that tinnitus may arise in any part of the hearing pathway (i.e., both within the cochlea receptor and in the temporal lobe and projections). Tinnitus also is associated frequently with vertigo, nausea and hearing loss. An age predominance exists, with tinnitus more common among those older than 40 years. From this starting point, a great demand exists today for new ideas and developments in the diagnosis and treatment of tinnitus.


Asunto(s)
Umbral Auditivo/efectos de los fármacos , Fitoterapia , Extractos Vegetales/uso terapéutico , Acúfeno/tratamiento farmacológico , Acúfeno/etiología , Enfermedades Vestibulares/complicaciones , Audiometría , Electronistagmografía , Potenciales Evocados Auditivos/efectos de los fármacos , Terapia por Ejercicio , Femenino , Ginkgo biloba , Humanos , Masculino , Persona de Mediana Edad , Acúfeno/fisiopatología , Resultado del Tratamiento , Enfermedades Vestibulares/fisiopatología
16.
Med Klin (Munich) ; 94 Suppl 3: 29-34, 1999 Oct 15.
Artículo en Alemán | MEDLINE | ID: mdl-10554525

RESUMEN

Monocytes differentiate from myeloid precursors towards the macrophage state of differentiation under the influence of 1,25-dihydroxy vitamins D3 (1,25 [OH]2 vitamin D3) and other factors and this is further propagated by colony stimulating factors (MCSF and GMCSF). Macrophage activation and phagocytosis of foreign particles are regularly accompanied by a so called "respiratory burst", an increase in the production of reactive oxygen species (ROS), exerted by the enzyme complex NADPH oxidase. A number of antioxidant enzymes is expressed at the same time to protect the cells from the cytotoxic effects of ROS directed against engulfed microorganisms. The selenium-dependent glutathione peroxidases and thioredoxin reductases are important examples. The cytosolic GPx isoenzyme (cGPx) and thioredoxin reductase alpha (TrxR alpha) are upregulated during the process of differentiation and under the influence of 1.25 (OH)2 vitamin D3. GPx isoenzymes neutralize H2O2. TrxR reduce sulfhydryl-groups like in cysteins either directly or via their cofactor thioredoxin and thus are involved in protein folding and critical protein-protein and protein-DNA interactions, e.g. modulation of dimerization and/or DNA-binding and ligand binding of transcription factors (glucocorticoid receptor and other steroid receptors, NF kappa B). In addition, the antibiotic peptide NK-lysin was shown to be a substrate for TrxR alpha, suggesting that TrxR protects the cell itself from the cytotoxic effects of NK-lysin. Selenium is incorporated into selenocysteine (Secys) in a regulated fashion in the presence of a hairpin structure (Secis element) in the 3'UTR of selenoprotein genes. Secis elements direct the insertion of Secys at UGA codons, which function as opal stop codons in the absence of a suitable Secis element and in selenium deficiency. The above mentioned processes might therefore be altered in relative selenium deficiency or vice versa be upregulated through selenium supplementation. We have shown that TrxR alpha is a 1.25 (OH)2 vitamin D3-responsive early gene in monocytic cells and that TrxR activity as well as GPx activity in these cells can be upregulated by the addition of selenium in vitro and ex vivo. Recent work demonstrates that thioredoxin rapidly enters the cell nucleus upon treatment of cells with H2O2, but little is known about the compartimentalization of the respiratory burst and the intracellular localization of antioxidant enzymes during that process. Macrophage function is insufficient if the generation of a respiratory burst is altered like in hereditary chronic granulomatous disease on one hand, but on the other hand is as well disturbed, if there is a lack in antioxidant enzyme activity. Thioredoxin has been identified as a lymphocyte growth factor and might therefore be involved in the crosstalk between macrophages and lymphocytes. The relevance of the above mentioned and other yet undefined monocytic selenoproteins remains to be elucidated in detail as well as the relevance of selenium supplementation in nutrition in general and in situations of critical infectious disease and autoimmunity.


Asunto(s)
Macrófagos/inmunología , Monocitos/inmunología , Neoplasias/inmunología , Proteínas/fisiología , Animales , Glutatión Peroxidasa/fisiología , Humanos , Selenoproteínas , Reductasa de Tiorredoxina-Disulfuro/fisiología
17.
Nervenarzt ; 69(12): 1037-44, 1998 Dec.
Artículo en Alemán | MEDLINE | ID: mdl-9888140

RESUMEN

For a large number of patients with stroke no therapeutic option can be offered, even after approval of thrombolytic therapy for treatment of acute ischemic stroke in the US. In cerebral ischemia local anoxia and energy failure lead to further cellular damage and finally to complete stroke. All therapeutic concepts try to salvage structurally intact tissue which is at risk for irreversible damage (so-called penumbra). Hyperbaric oxygen (HBO) treatment has been reported in animal models of cerebral ischemia, and in a few clinical reports. In general, the results of these studies have been promising. This review focuses on the clinical perspective of HBO therapy and summarizes both the clinical and experimental data available on HBO therapy following ischemic stroke.


Asunto(s)
Infarto Cerebral/terapia , Oxigenoterapia Hiperbárica , Hipoxia Encefálica/terapia , Enfermedad Aguda , Infarto Cerebral/diagnóstico , Humanos , Hipoxia Encefálica/diagnóstico , Resultado del Tratamiento
18.
Semin Oncol Nurs ; 13(4): 263-70, 1997 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9392035

RESUMEN

OBJECTIVES: To review literature pertinent to spirituality of children with cancer and to identify practical strategies for providing care for this dimension in children. DATA SOURCES: Nursing research and literature about pediatric nursing care and spirituality; theoretical formulations of Piaget, Fowler, and Erikson. CONCLUSION: Children diagnosed with cancer have unique spiritual needs that place them at risk for developing spiritual distress. With the diagnosis may come experiences of loss of normalcy, physical stamina, relationships, body image, and future goals. Spiritual care includes interventions that assist children to find meaning and purpose in life, to continue relationships, and to transcend beyond the self. IMPLICATIONS FOR NURSING PRACTICE: Spiritual care includes caregiver and child assessment and interventions appropriate to the developmental stages of infancy through adolescents. Tables outlining how this can be done by oncology nurses are included.


Asunto(s)
Enfermería Holística/métodos , Neoplasias/psicología , Religión y Psicología , Adolescente , Niño , Desarrollo Infantil , Preescolar , Humanos , Lactante , Masculino , Neoplasias/enfermería , Evaluación en Enfermería , Psicología Infantil
19.
Electroencephalogr Clin Neurophysiol ; 103(4): 450-6, 1997 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-9368490

RESUMEN

Sixteen patients with partial epilepsy learned to produce positive or negative slow cortical potential shifts in a biofeedback condition during 20 consecutive training sessions. Visual ERPs to the presentation of the feedback and the discriminative stimulus were recorded at vertex. Regardless of the subjects' task (positivity versus negativity), amplitudes of the P2 (mean peak latency about 225 ms) and P3a (322 ms) components decreased across sessions, resulting in appearance and subsequent enhancement of a negative wave N2 (298 ms) between P2 and P3a. As N2 grew the P2 latency decreased and the P3a latency increased. Additionally, the P3b (472 ms) decreased with repetition, however, it did so slower than P2 and P3a. A comparison between the present data, on the one hand, and those obtained in the ERP habituation paradigm within one session, on the other hand, indicates that some repetition effects cannot be explained by habituation.


Asunto(s)
Epilepsia/fisiopatología , Potenciales Evocados Visuales/fisiología , Habituación Psicofisiológica/fisiología , Adulto , Biorretroalimentación Psicológica , Femenino , Humanos , Masculino , Tiempo de Reacción , Factores de Tiempo
20.
Aust J Sci Med Sport ; 29(3): 65-8, 1997 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-9302488

RESUMEN

Nine untrained male subjects participated in a placebo (Pl)/creatine (Cr), single-blind study conducted over a 5-wk period. Placebo and Cr treatments were presented in a sequential manner because muscle Cr washout time after supplementation is unknown. The mean ( +/- SE) age, height, and initial body mass for the subjects was 25.7+/- 1.2 yr, 177 +/- 2 cm, and 78.5 +/- 3.8 kg, respectively. Each subject performed five 15-s bouts of maximal cycling (1-min rest periods) after 7 d of Pl (6 g glucose X 5 doses daily) and again after ingesting Cr for 7 d (5 g creatine plus 1 g glucose X 5 doses) with a 2-wk intervention period. Only 6 of 9 subjects were able to complete five 1-min bouts of maximal cycling (5-min rest periods) after an additional 2 d of Pl and Cr treatment. Cr ingestion resulted in a significant increase in the work performed during each 15-s bout of maximal cycling compared to Pl trials. Moreover, the total work completed during five 15-s bouts of cycling increased significantly from 47.5 +/- 2.3 kJ with Pl treatment to 50.6 +/- 2.3 kJ after Cr supplementation (P < 0.05). Peak blood lactate concentrations determined 4 min after the fifth 15-s work bout were 14.4 +/- 0.5 mmol.L-1 and 14.3 +/- mmol.L-1 for Pl and Cr trials, respectively (P < 0.05). Total work completed during five 1-min bouts of maximal cycling was not significantly increased after Cr supplementation (P > 0.05). Additionally, Cr supplementation did not slow the rate of decline in the work accomplished during repeated bouts of maximal cycling. These findings suggest that Cr ingestion may augment the rate of ATP resynthesis from phosphocreatine during exercise in untrained subjects.


Asunto(s)
Creatina/administración & dosificación , Suplementos Dietéticos , Prueba de Esfuerzo , Tolerancia al Ejercicio/efectos de los fármacos , Músculo Esquelético/efectos de los fármacos , Administración Oral , Adulto , Ciclismo/fisiología , Prueba de Esfuerzo/efectos de los fármacos , Humanos , Masculino , Músculo Esquelético/metabolismo , Valores de Referencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA